Komunikaty PR

Biomed Industries, Inc. to Present Phase 2 Results on NA-931—An Oral Alternative to Injectables for Obesity—at ADA 2025

2025-05-05  |  14:55:05
Biomed logo

Biomed Industries, Inc. logo

Biomed pipeline

Biomed pipeline

NA-931 for weight loss

NA-931 for weight loss

Biomed Industries, Inc. to Present Phase 2 Results on NA-931—An Oral Medicine Alternative to Injectables for Obesity—at ADA Conference 2025 in Chicago

We believe the future of obesity treatment lies in safe, effective, and accessible oral therapies. NA-931 is a first-in-class innovation that provides an oral alternative to injectable drugs”
— Dr. Lloyd L. Tran, CEO of Biomed
SAN JOSE, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Biomed Industries, Inc. (“Biomed”) today announced that Dr. Lloyd L. Tran, the company’s Chief Executive Officer, will present results from its Phase 2 clinical trial of NA-931, a first-in-class oral quadruple receptor agonist for the treatment of obesity, at the 85th Scientific Sessions of the American Diabetes Association (ADA), taking place June 20–23, 2025, in Chicago, Illinois.

Dr. Tran’s oral presentation, scheduled for June 20, is titled:
“Phase 2 Clinical Trials of NA-931, an Oral Novel Quadruple IGF-1, GLP-1, GIP, and Glucagon Receptor Agonist, Reduces Body Weight Without Muscle Loss.”

The Phase 2 study was a randomized, double-blind, placebo-controlled, parallel-arm clinical trial evaluating the safety, tolerability, efficacy, pharmacodynamics, and pharmacokinetics of NA-931 in adults with obesity (BMI ≥30 kg/m²) or who are overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity.

Completed in April 2025, the Phase 2 trial confirmed the robust efficacy and favorable safety profile seen in Phase 1. NA-931 achieved weight loss outcomes on par with leading approved and late-stage injectable therapies, while showing significantly fewer and milder side effects. Topline data are currently under embargo and will be revealed during Dr. Tran’s ADA presentation.

In addition to the oral presentation, Biomed will present a scientific poster titled:
“Association Between Alzheimer’s Disease (AD) and Obesity: Clinical Trial Results of NA-831 for AD and NA-931 for Obesity.”

Biomed’s research team is among the first to identify the possible mechanistic link between obesity and Alzheimer’s disease, driven by its dual development programs in NA-831 (for AD) and NA-931 (for obesity).

The ADA Scientific Sessions is the world’s largest conference on diabetes and metabolic disorders, drawing over 11,000 attendees, including physicians, scientists, and pharmaceutical industry leaders. The 2025 conference will be held at McCormick Place Convention Center in Chicago.

“We are honored and excited to present our promising Phase 2 data for NA-931 at this prestigious conference,” said Dr. Lloyd Tran, CEO of Biomed Industries. “We believe the future of obesity treatment lies in safe, effective, and accessible oral therapies. NA-931 is a first-in-class innovation that provides an oral alternative to injectable drugs. We look forward to sharing our data with the global scientific community.”

THE GROWING NEED FOR OBESITY TREATMENT
Obesity affects more than 650 million people worldwide and is driven by a complex mix of genetic, environmental, and behavioral factors. It is associated with type 2 diabetes, cardiovascular disease, non-alcoholic liver disease, and chronic kidney disease.
Despite recent advances in weight loss therapeutics, many available treatments do not address the full biological complexity of obesity. By 2035, more than 4 billion people—over 50% of the global population—are projected to be overweight or obese, highlighting the urgent need for innovative, multi-targeted therapies like NA-931.

ABOUT BIOMED INDUSTRIES, INC.
Biomed Industries, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for chronic and complex diseases. The company’s investigational pipeline targets a wide range of unmet medical needs, including:

- Alzheimer’s disease
- Major depressive disorder (MDD)
- Obesity and diabetes
- Metabolic dysfunction-associated steatohepatitis (MASH)
- Stroke and alcohol use disorder
- Rare diseases, including Rett Syndrome

For more information, visit: https://www.biomedind.com
Media Contact:

Michael Willis
Biomed Industries, Inc.
+1 800-824-5135
email us here
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-06-05 | 02:55:06

CWR Central Expands In-House Capabilities: Parts, Service, Installation & Custom Design Solutions

YAKIMA, WA, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- CWR Central, a leading provider in Industrial Refrigeration solutions. CWR is not just a supplier, they are a strategic partner delivering unmatched expertise in parts supply, technical service, full installation, retrofitting, and custom system designs. With decades of experience and a commitment to excellence, Central Washington Refrigeration is redefining convenience and reliability for customers across industries. From project conception to completion, CWR Central offers end-to-end solutions under one roof—minimizing downtime, optimizing system performance, and delivering long-term value to every customer. CWR Central’s In-House Services Include: • Extensive Parts Inventory: Fast access to essential and specialty parts, backed by knowledgeable support staff to ensure their customers get exactly what they need • Expert Technical Service: Factory-trained technicians are available for diagnostics, maintenance, repairs, and service calls across a wide range of systems. • Full System Installations: Turnkey installation services tailored to industrial applications—completed efficiently, safely, and to exacting standards. • Retrofit Solutions: Modernize existing systems for improved efficiency, compliance, and cost savings. CWR Central provides retrofit assessments, planning, and seamless execution. • Custom Design & Engineering: Experienced engineering team to design solutions that meet their customer's exact needs, whether for new builds or upgrades. With a reputation for integrity, innovation, and customer-first service, CWR Central continues to lead the way in delivering high-performance solutions that keep operations running smoothly across industries. Availability To explore their full range of services or to request a quote, visit www.cwrcentral.com/ or contact their service team directly.
EIN Newswire BRAK ZDJĘCIA
2025-06-05 | 02:55:06

U.S. House Passes FASD Authorization in the Support Act: Legislation Will Deliver Support to Individuals with FASD

Advocates gather in front of the U.S. Capitol during FASD Awareness MonthAdvocates for FASD Support in Washington, DCHistoric Congressional action marks milestone in FASD policy and moves community closer to achieving comprehensive Federal
EIN Newswire BRAK ZDJĘCIA
2025-06-05 | 02:55:06

This Week Exclusive Interview at New York Art Life Magazine with Expert Graphic Designer Heer Mandalia

Heer MandaliaFrom the Beginning to Defining Global Brand Narratives at NBCUniversalMy work focuses on developing impactful advertising products for major brands on Peacock and designing key visuals for high-profile NBCU events, contributing to

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Rady Podatkowej

Targi Bezpieczeństwa

Handel

Branża materiałów budowlanych ostrzega przed rosnącym importem ze Wschodu. Rząd zapowiada działania w tym kierunku

Polscy przedstawiciele branży materiałów budowlanych są zaniepokojeni skalą importu wyrobów spoza Unii Europejskiej. Postępujące uzależnienie europejskiego rynku od dostaw z krajów o niższych standardach środowiskowych, pracowniczych i jakościowych skutkuje nie tylko osłabieniem jego konkurencyjności, spadkiem krajowej produkcji i redukcją miejsc pracy, ale również ucieczką emisji CO2. Branża apeluje więc o wprowadzenie zmian w zakresie handlu, w tym o wyrównanie stawek celnych na materiały budowlane. Rząd zapowiada podjęcie działań, które będą wspierać krajową branżę.

Ochrona środowiska

Rusza ważna inwestycja w Ustce. Nowa baza będzie zapleczem serwisowym dla morskich farm wiatrowych [AUDIO]

Wystartowały prace przy budowie bazy operacyjno-serwisowej w Ustce. Inwestycja będzie zapleczem dla obsługi morskiej farmy wiatrowej, którą PGE buduje na Bałtyku wraz z duńską firmą Ørsted. Uruchomienie Baltica 2 zaplanowane jest na 2027 rok. Baza ma także potencjał, by obsługiwać kolejne projekty morskie PGE. Będzie mieć znaczenie nie tylko dla rozwoju offshore w Polsce, lecz także dla samego regionu.

Handel

Rynek nieprzygotowany do wdrożenia systemu kaucyjnego. Może się opóźnić nawet o kilka miesięcy

Zdaniem przedstawicieli Polskiej Federacji Producentów Żywności Polska nie jest jeszcze przygotowana na wprowadzenie systemu kaucyjnego 1 października br. Za główny powód opóźnień podają brak licencji, które mogą powodować potężne straty finansowe. Eksperci wskazują, że system może ruszyć z kilkumiesięcznym opóźnieniem, co spowoduje chaos zarówno wśród konsumentów, jak i w handlu.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.